...
首页> 外文期刊>Chinese Medical Journal >Methylation of p16 gene in hematological malignancies
【24h】

Methylation of p16 gene in hematological malignancies

机译:血液系统恶性肿瘤中p16基因的甲基化

获取原文
获取原文并翻译 | 示例

摘要

Conclusion The methylation of p16 gene plays an important role in the pathogenesis and the develop- ment of some hematological malignancies. The pa- tients with p16 gene methylation have poor prognosis. The detection of p16 gene is a useful tool for evaluation Prognosis of hematological malignancies. Objective To investigate the incidence of p16 Gene methylation in hematological malignancies, and The relations between p16 gene methylation and the Prognosis of hematological malignancies. Methods Fifty-five patients were studied by re- Striction nezyme polymerase chain reaction (PCR) to Detect p16 gene methylation.
机译:结论p16基因的甲基化在某些血液系统恶性肿瘤的发病机理和发展中起着重要作用。 p16基因甲基化的患者预后较差。 p16基因的检测是评估血液系统恶性肿瘤预后的有用工具。目的探讨p16基因甲基化在血液系统恶性肿瘤中的发生率,以及p16基因甲基化与血液系统恶性肿瘤预后的关系。方法对55例患者进行Restriction酶聚合酶链反应(PCR)检测p16基因甲基化的研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号